FDA Extends Saleable Returns Verification Until 2023
October 23, 2020

FDA Extends Saleable Returns Verification Until 2023

FDA is concerned that large volume of saleable returns coupled with the challenges of establishing reliable and robust technology may disrupt the distribution of prescription drugs in the United States. FDA does not intend to take action against wholesale distributors who do not, prior to November 27, 2023, verify the product identifier prior to further distributing returned product. This is a 3-year delay from the current date of enforcement. FDA also does not intend to take action against dispensers who do not verify the product identifiers of suspect product as required by DSCSA before November 27, 2023.
Read More
How to Ensure Conformance to EPCIS Standards in Drug Traceability
July 3, 2020

How to Ensure Conformance to EPCIS Standards in Drug Traceability

To attain electronic, interoperable pharmaceutical traceability, each member of the drug supply network must connect and exchange information. Conformance certification ensures consistency among trading partners, aligns data structures, enables common data definitions, and avoids deployment delays.
Read More
EPCIS Data Exchange Issues in Pharma Traceability
June 20, 2020

EPCIS Data Exchange Issues in Pharma Traceability

Gary Lerner, Gateway Checker’s president, is featured in a recent Healthcare Packaging article, "3 EPCIS Data Exchange Issues in Pharma Traceability," focusing on how pharmaceutical companies are continuing to make progress to meet the upcoming DSCSA 2023 requirements for unit-level traceability.
Read More
GS1 Connect – Bridging the Gap
June 8, 2020

GS1 Connect – Bridging the Gap

Join Jeff Denton (AmerisourceBergen) and Gary Lerner (Gateway Checker) as they discuss how to bridge the gap to US Drug traceability at the GS1 Connect Digital Conference, June 16 and 17. GS1 Connect: Bridging the Gap to Pharmaceutical Traceability FDA regulations mandates interoperable, electronic tracing of medicines at the item level to enhance the security […]
Read More
Gateway Checker’s Gary Lerner to Discuss Pharmaceutical Traceability at GS1 Connect
June 8, 2020

Gateway Checker’s Gary Lerner to Discuss Pharmaceutical Traceability at GS1 Connect

Gary Lerner, president and founder of Gateway Checker and expert on supply chain integrity, will be discussing the future of pharmaceutical traceability at the GS1 Connect virtual conference, taking place June 16-17, 2020. Gary, together with Jeff Denton of AmerisourceBergen, will present “Bridging the Gap to Pharmaceutical Traceability” as an On Demand session, which will […]
Read More